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Abstract An alternative mevalonate-independent pathway for
isoprenoid biosynthesis has been recently discovered in eubacte-
ria (including Escherichia coli) and plant plastids, although it is
not fully elucidated yet. In this work, E. coli cells were
engineered to utilize exogenously provided mevalonate and used
to demonstrate by a genetic approach that branching of the
endogenous pathway results in separate synthesis of the
isoprenoid building units isopentenyl diphosphate (IPP) and its
isomer dimethylallyl diphosphate (DMAPP). In addition, the
IPP isomerase encoded by the idi gene was shown to be
functional in vivo and to represent the only possibility for
interconverting IPP and DMAPP in this bacterium.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Isoprenoids (also called terpenoids) are the most chemically
diverse family of compounds found in nature. They are
present in all organisms and have essential roles in membrane
structure, redox chemistry, reproductive cycles, growth regu-
lation, signal transduction and defense mechanisms. In spite
of their diversity of functions and structures, all isoprenoids
derive from the common building C5 isoprene units isopen-
tenyl diphosphate (IPP) and its isomer dimethylallyl diphos-
phate (DMAPP). Isoprenoid synthesis is accomplished by a
head to tail addition of IPP units to DMAPP by various
prenyltransferases to form prenyl diphosphates of di¡erent
chain length. Further dimerization and cyclization reactions
yield the ¢nal carbon skeleton of isoprenoids [1,2].
Following the discovery of the mevalonate pathway in the
1950s, it was believed that all isoprenoids derived from meva-
lonic acid (MVA) synthesized by the condensation of three
acetyl-CoA units via aceto-acetyl-CoA and 3-hydroxy-3-meth-
ylglutaryl-CoA. Subsequent phosphorylation and decarboxy-
lation of MVA catalyzed by mevalonate kinase (MVK), phos-
phomevalonate kinase (PMK) and mevalonate diphosphate
decarboxylase (MDD) yield IPP, which is then converted to
DMAPP by the enzyme IPP isomerase [3]. Recent experiments
(reviewed in [4^6]) have demonstrated, however, that the iso-
prenoids synthesized in plant plastids and many eubacteria,
including Escherichia coli, derive from IPP and DMAPP pro-
duced by a di¡erent pathway ¢rst described by Rohmer et al.
[7] (Fig. 1). The initial reaction of this MVA-independent
pathway involves the formation of 1-deoxy-D-xylulose 5-phos-
phate (DX5P) by condensation of (hydroxyethyl)thiamine di-
phosphate derived from the decarboxylation of pyruvate with
the C1 aldehyde group of D-glyceraldehyde 3-phosphate [8,9].
This reaction is catalyzed by 1-deoxy-D-xylulose 5-phosphate
synthase, a novel type of transketolase encoded by the dxs
gene in E. coli [10^12]. In the second step, the enzyme
DX5P reductoisomerase (encoded by the dxr gene, previously
known as yaeM in E. coli) synthesizes 2-C-methyl-D-erythritol
4-phosphate (ME4P) by intramolecular rearrangement and
reduction of DX5P [13^15]. Then, ME4P can react with
CTP to form 4-diphosphocytidyl-2-C-methyl-D-erythritol
(CDP-ME), in a reaction catalyzed by the enzyme speci¢ed
by the ygbP gene from E. coli [16,17]. Recently, it has been
shown that ychB, another E. coli gene reported to be involved
in the pathway, encodes a kinase that phosphorylates the
2-hydroxy group of CDP-ME [18]. The resulting product,
4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate, can
be then converted by the product of the ygbB gene to 2-C-
methyl-D-erythritol 2,4-cyclodiphosphate, the proposed next
intermediary of the pathway [19]. The remaining enzymatic
reactions leading to the synthesis of the C5 isoprene unit
have not yet been fully elucidated.
Analysis of the fate of the hydrogen atoms of deuterium-
labeled 2-C-methyl-D-erythritol (ME) and 1-deoxy-D-xylulose
(DX) added to the culture medium of E. coli cells [20,21], and
studies on the stereochemistry of E. coli IPP isomerase en-
coded by the idi gene and farnesyl diphosphate (FPP) syn-
thase encoded by the ispA gene [22^24] have led to the pro-
posal of the presence of two di¡erent routes towards IPP and
DMAPP starting from a common intermediate derived from
ME4P (Fig. 1). Consistent with this hypothesis, the disruption
of the idi gene encoding IPP isomerase is not lethal in E. coli
[25]. Isoprenoids are required for essential functions in E. coli,
including respiration (ubiquinone) and cell wall biosynthesis
(dolichol). Therefore, the normal growth of cells with a dis-
rupted, non-functional idi gene indicates that either there are
two independent routes for the synthesis of IPP and DMAPP
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or that a second possibility to interconvert both C5 units is
present in E. coli. In this paper we have engineered E. coli
cells to utilize exogenously provided MVA for the production
of IPP and used a genetic approach to demonstrate that
branching of the isoprenoid pathway occurs, resulting in sep-
arate synthesis of IPP and DMAPP. We also show that idi
functions in converting IPP to DMAPP in vivo and that it is
the only gene encoding an enzyme with such activity in E. coli.
2. Materials and methods
2.1. Plasmid constructs
Plasmids pUC19 (Pharmacia), pBR322 (Gibco-BRL) and pGEM-T
(Promega) were used as vectors for the preparation of constructs to
disrupt the dxr and idi genes in E. coli. A genomic region containing
the dxr gene and extending from the 5P-end of frr to the 3P-end of
yaeS (Fig. 2A) was ampli¢ed by polymerase chain reaction (PCR)
using primers d1 (5P-GCACACTTCCACTGTGTGTG-3P) and d2
(5P-CCGCATAACACCGCCAACC-3P), digested with BglII and
SphI (Fig. 2A) and cloned in pUC19 previously digested with BamHI
and SphI to produce plasmid pMJ4. The dxr gene in pMJ4 was dis-
rupted by the substitution of a 0.7 kb EcoRI^NcoI fragment with the
coding region of the marker gene conferring resistance to tetracyclin
(TET ; Fig. 2A) released from pBR322 after digestion with EcoRI and
P£MI to produce plasmid pMJ5. A SmaI^HindIII fragment from
pMJ5, containing the BglII^SphI genomic region with the dxr: :TET
disruption, was then cloned in the AccB71^HindIII sites of pBR322,
generating pMJ6.
For disruption of the idi gene, the £anking chromosome region was
ampli¢ed by PCR using primers iF (5P-CCCAAGCTTCATG-
GTTTGCGATTGTTACGC-3P, annealing on the ygfU gene) and iR
(5P-CGGGATCCTCTCTGGTATTCGC-3P, annealing on the lysS
gene) (Fig. 2B) and the resulting 2.5 kb fragment was cloned into
pGEM-T to produce pCM1. The CAT gene, conferring resistance
to chloramphenicol, was excised from plasmid pCAT19 [26] by Bam-
HI digestion and cloned into the BclI site at the 5P-end of the idi gene
in pCM1. A PCR fragment ampli¢ed with primers iPstI (5P-GG-
ATGGTGCTGCAGGCGACAAATCG-3P, annealing on the 3P-end
of the idi gene; Fig. 2B) and SP6 (annealing on the SP6 promoter
region of pGEM-T) from pCM2-4, in which the CAT gene was cloned
in the same transcriptional direction as the rest of the genes in the
region (Fig. 2B), was cloned back into pCM2-4 after digestion of both
the plasmid and the PCR product with PstI to generate pCMa2, in
which the idi gene (except the 3P last 60 nucleotides) was replaced by
the CAT gene (Fig. 2B).
The synthetic operon to express the coding region of Saccharomyces
cerevisiae ERG12 (MVK) and ERG19 (MDD) genes and the human
PMK cDNA under the control of the arabinose-inducible PBAD pro-
moter was constructed in a modi¢ed version of plasmid pBAD-
GFPuv (Clontech) to create pAB-M2 (Campos et al., in preparation).
2.2. Growth conditions
All strains were grown at 37‡C in Luria broth (LB) medium sup-
plemented with tetracyclin (7.5 Wg/ml, for selection of the dxr: :TET
disruption), chloramphenicol (17 Wg/ml, for selection of the idi: :CAT
disruption) or/and ampicillin (100 Wg/ml, for selection of cells carrying
the pAB-M2 plasmid). When indicated, the growth medium was sup-
plemented with 0.5 mM ME (synthesized as described [27]), 0.02%
(w/v) arabinose or/and 1 mM MVA prepared from a stock of meva-
lonolactone (Sigma) hydrolyzed by incubating 1 volume of 1 M me-
valonolactone with 1.02 volumes of 1 M KOH at 37‡C for 30 min.
2.3. Bacterial strains
Some of the bacterial strains used in this work are listed in Table 1.
For the construction of a dxr-defective strain, plasmid pMJ6 was
linearized and used to transform strain JC7623 cells, in which the
recB21, recC22 and sbcB15 mutations allow transformation by linear
DNA [28]. Transformed cells with the chromosomal dxr: :TET dis-
ruption were selected on LB medium containing tetracyclin and ME.
The disruption was con¢rmed in colonies showing both tetracyclin
resistance and ME auxotrophy by PCR analysis with primers d3
(5P-CTCTGGATGTCATATGAAGCAACTC-3P) and d2 (Fig. 2A).
Bacteriophage P1 lysates obtained after infection of one of the se-
lected JC7623 dxr: :TET clones was used to transduce the disruption
into strain MC4100 [29] (Table 1) as described [30]. The resulting
MC4100 dxr: :TET strain was designated EcAB1-2.
A JC7623 idi: :CAT strain was constructed after transformation of
JC7623 cells with a puri¢ed PCR product ampli¢ed from plasmid
pCMa2 with primers iF and iR. Transformed cells harboring the
disrupted idi gene were selected on LB medium containing chloram-
phenicol. The disruption was con¢rmed by PCR analysis with primers
iFo (5P-GCTAGCATCATTCAGGTGG-3P) and iR (Fig. 2B) and
transduced into strain MC4100 using bacteriophage P1 lysates ob-
tained from JC7623 idi: :CAT cells. The resulting MC4100 idi: :CAT
strain was designated EcAB1-3. The same JC7623 idi: :CAT lysate
was also used to transduce the idi: :CAT disruption to strain
EcAB1-2, creating the MC4100 dxr: :TET idi: :CAT strain EcAB1-
4. Strains EcAB1-2(pAB-M2) and EcAB1-4(pAB-M2) were con-
structed after transformation of EcAB1-2 and EcAB1-4 cells, respec-
tively, with plasmid pAB-M2 (Table 1).
3. Results and discussion
A genetic approach was taken in order to elucidate the
metabolic framework for the synthesis of IPP and DMAPP
in E. coli. Basically, the approach was to (i) create an E. coli
strain impaired in the synthesis of ME4P and thus unable to
synthesize IPP and DMAPP through the endogenous MVA-
independent pathway, (ii) engineer it to synthesize IPP from
exogenously supplied MVA and then (iii) evaluate the role of
the IPP isomerase encoded by the idi gene in the conversion of
the MVA-derived IPP into DMAPP.
A complete block of isoprenoid production was accom-
plished in a strain with a disruption of the dxr gene, encoding
the enzyme responsible for the production of ME4P, the pro-
posed ¢rst precursor speci¢c of the pathway (Fig. 1) [15]. For
the construction of the dxr-defective strain, an EcoRI^NcoI
fragment from the central region of the dxr gene was replaced
with a selectable marker conferring resistance to tetracyclin
(TET ; Fig. 2A). The corresponding construct was linearized
and used to transform E. coli strain JC7623, in which the recB
Fig. 1. Isoprenoid biosynthetic pathway in E. coli and engineered
synthesis of IPP from exogenously supplied MVA. G3P, D-glyceral-
dehyde 3-phosphate; DX5P, 1-deoxy-D-xylulose 5-phosphate; dxr,
1-deoxy-D-xylulose 5-phosphate reductoisomerase; ME4P, 2-C-meth-
yl-D-erythritol 4-phosphate; DMAPP, dimethylallyl diphosphate;
IPP, isopentenyl diphosphate; idi, IPP isomerase; MVA, mevalonic
acid; MVK, mevalonate kinase; PMK, phosphomevalonate kinase;
MDD, mevalonate diphosphate decarboxylase.
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and recC mutations inactivate exonuclease, preventing it from
degrading the linear DNA, whereas the sbcB mutation re-
stores recombination pro¢ciency [28]. After transformation,
cells in which the dxr gene had been replaced by the
dxr: :TET disrupted version were selected on plates supple-
mented with tetracyclin. Since the disruption in the dxr gene
was designed to block the production of isoprenoids (Fig. 1)
and therefore was predicted to be lethal in the absence of a
source of intermediates for their biosynthesis, ME was also
added to the plates. ME was used instead of ME4P since it is
known that E. coli cells with disrupted genes of the isoprenoid
pathway are capable of e⁄ciently using free ME to synthesize
isoprenoids [20]. The presence of the dxr: :TET disruption in
the bacterial chromosome was con¢rmed by PCR analysis.
For further studies, the dxr: :TET disruption was transferred
from strain JC7623, which is not a good host for supporting
replication of plasmids [28], to strain MC4100 (Table 1) by
phage P1 transduction. The MC4100 dxr: :TET strain was
designated EcAB1-2. As expected, EcAB1-2 cells required
ME for growth and survival (Fig. 3), con¢rming that the
insertional disruption of the dxr gene prevents the synthesis
of ME4P and therefore is functional in blocking the produc-
tion of isoprenoid intermediates.
To evaluate whether an alternative pathway for the produc-
tion of IPP could rescue ME auxotrophy in EcAB1-2 cells, we
engineered E. coli for the utilization of MVA, an isoprenoid
precursor that is not synthesized in this bacterium. For the
cells to be able to transform MVA into IPP, they were trans-
formed with plasmid pAB-M2 harboring a synthetic operon
containing the coding regions of Saccharomyces cerevisiae
genes ERG12 (encoding MVK) and ERG19 (encoding
MDD) and the human PMK cDNA (Fig. 1). The expression
of the operon in pAB-M2 was under the control of the PBAD
promoter, which can be induced with arabinose. Transforma-
tion of EcAB1-2 cells with pAB-M2 yielded strain EcAB1-
2(pAB-M2). This strain grew normally on LB plates contain-
ing ME, but it was also able to grow on LB plates supple-
mented with arabinose and MVA (Fig. 3), con¢rming that
pAB-M2 contained a functional operon encoding the enzymes
required for the synthesis of IPP from MVA in E. coli. In
addition, the results also indicated the presence of an endog-
enous enzymatic activity that was active in converting the
MVA-derived IPP into DMAPP.
Synthesis of DMAPP in dxr-defective EcAB1-2(pAB-M2)
cells grown in the presence of MVA could be accomplished
either by the IPP isomerase encoded by the idi gene, by a
di¡erent enzyme encoded by another gene that could also
function as an IPP isomerase or by several enzymes allowing
the interconversion of IPP and DMAPP. To elucidate the role
of idi in the synthesis of DMAPP from IPP, a derivative of
strain EcAB1-2(pAB-M2) harboring a disruption in the idi
gene was generated. Replacing the almost entire coding se-
quence of the idi gene with a selectable marker gene encoding
chloramphenicol acetyltransferase (CAT ; Fig. 2) created the
idi: :CAT disruption. JC7623 strain was transformed with the
PCR-ampli¢ed linear construct and cells harboring a genomic
idi: :CAT disruption were selected on LB plates supplemented
with chloramphenicol. As described above for dxr: :TET, the
presence of the idi: :CAT disruption in the bacterial chromo-
some was con¢rmed by PCR analysis and then transduced to
Fig. 2. Insertional disruption of the dxr and idi genes of E. coli. A:
Genomic region £anking the dxr gene in wild type E. coli (upper
scheme) and in the dxr: :TET strains (lower scheme). Arrowheads
indicate position of primers d1, d2 and d3. B: Genomic region
£anking the idi gene in wild type E. coli (upper scheme) and in the
idi: :CAT strains (lower scheme). Position of primers iFo, iF and iR
is shown. Arrows indicate direction of transcription and bars indi-
cate the regions used for transformation of strain JC7623 cells.
Table 1
Bacterial strains used in this study
Strain Description
MC4100 F3 araD139 v(argF-lac)U169 relA1 rpsL150
£bB5301 strA thi deoC7 ptsF25 [29]
EcAB1-2 MC4100 dxr: :TET
EcAB1-2(pAB-M2) MC4100 dxr: :TET transformed with pAB-M2
EcAB1-3 MC4100 idi: :CAT
EcAB1-4 MC4100 dxr: :TET idi: :CAT
EcAB1-4(pAB-M2) MC4100 dxr: :TET idi: :CAT transformed with
pAB-M2
Fig. 3. Growth of the E. coli strains indicated in (A) on plates con-
taining LB medium supplemented with tetracyclin and either ME
(B), arabinose (C) or MVA and arabinose (D).
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strain MC4100 using phage P1. The obtained MC4100 idi: :
CAT strain was named EcAB1-3. As previously reported [25],
the absence of the IPP isomerase encoded by idi had no ap-
parent harmful e¡ects for growth and survival of E. coli
EcAB1-3 cells (data not shown), con¢rming that idi is a
non-essential gene. The idi: :CAT disruption was then trans-
ferred to strain EcAB1-2 by P1 transduction to generate strain
EcAB1-4 harboring a double disruption at the dxr and idi
genes (Table 1). Similar to EcAB1-2, EcAB1-4 cells grew in
the presence of ME (Fig. 3). These results indicate that, if
there is only one route for the biosynthesis of either DMAPP
or IPP in E. coli, isomerization is not accomplished by the IPP
isomerase encoded by idi, thus requiring another possibility to
interconvert IPP and DMAPP. The presence of a second gene
encoding IPP isomerase, however, appears unlikely since no
other sequences showing homology to IPP isomerases from
bacterial, fungal, plant or animal sources were identi¢ed in
the E. coli genome after databases searches [25]. Alternatively,
our results could be explained by a branching point after
ME4P resulting in the independent synthesis of IPP and
DMAPP. This possibility has been recently proposed based
on experiments of feeding of E. coli cells with deuterium-la-
beled ME [20]. The C3 deuterium of [3,5,5,5-2H4]ME was
only preserved in the DMAPP-derived isoprenic units but
was completely lost in all those formed from IPP, suggesting
the presence of two di¡erent routes towards IPP and DMAPP
in E. coli [20]. Previous evidence for the independent synthesis
of IPP and DMAPP came from studies on the incorporation
of deuterium-labelled DX in ubiquinone [21] and the stereo-
chemistry of the E. coli IPP isomerase encoded by idi and FPP
synthase encoded by ispA [22,24]. When [4-2H]DX was fed to
E. coli cultures, the label was incorporated exclusively at the
C2 position of the 9 isoprenoid unit in the side chain of
ubiquinone, which arises from DMAPP [21]. Since both IPP
isomerase and FPP synthase show the same stereochemistry
observed for the eukaryotic enzymes [22,24], the DMAPP in-
corporated into the 9 position of the ubiquinone can not be
synthesized from IPP by the action of the isomerase encoded
by idi. These results suggested that either IPP and DMAPP
are synthesized independently from an as yet unidenti¢ed in-
termediate or another isomerase activity with a di¡erent
stereospeci¢city exists in E. coli.
To discriminate between the two hypotheses (or con¢rm
both), the idi: :CAT disruption was transferred to strain
EcAB1-2(pAB-M2) by P1 transduction. Cells harboring
both dxr: :TET and idi: :CAT disruptions and the pAB-M2
plasmid were selected on LB plates supplemented with tetra-
cyclin, chloramphenicol, ampicillin and ME. The presence of
the dxr and idi insertional disruptions in the chromosome of
the new strain, designated EcAB1-4(pAB-M2), was veri¢ed by
PCR analysis. EcAB1-4(pAB-M2) cells grew normally in LB
medium containing ME but they did not grow at all when the
LB medium was supplemented with arabinose and MVA (Fig.
3). The obligatory requirement of ME for growth of EcAB1-
4(pAB-M2) cells indicated that MVA-derived IPP could not
be isomerized to DMAPP in the idi: :CAT genetic back-
ground. A possibility existed, however, that pAB-M2 was
not functional in EcAB1-4(pAB-M2) cells and therefore no
IPP was synthesized from MVA. To con¢rm that pAB-M2
remained functional, EcAB1-2 cells containing the dxr: :TET
disruption were transformed with plasmid pAB-M2 isolated
from strain EcAB1-4(pAB-M2). The positive clones resulting
from the transformation were able to grow in medium con-
taining MVA as the only source for the production of IPP
(data not shown), similar to that reported above for strain
EcAB1-2(pAB-M2) (Fig. 3). Together, these results demon-
strate that the enzyme encoded by the idi gene represents
the only possibility of interconverting IPP and DMAPP in
E. coli. The identity of idi as a gene encoding IPP isomerase
had been established biochemically, but the absence of other
known genes for enzymes of the isoprenoid pathway in the
same cluster and its non-essential function in E. coli pointed
against an active role in the synthesis of isoprenoids [25]. Our
results show, however, that idi can function in converting IPP
to DMAPP in vivo and that it actually plays a role in iso-
prenoid biosynthesis. In spite of its non-essential role during
normal growth and survival of E. coli cells, it can be specu-
lated that the IPP isomerase encoded by the idi gene might
have a role in certain metabolic situations. Furthermore, since
no other enzyme with IPP isomerase activity exists in E. coli,
the results obtained with strain EcAB1-4 indicate that the
isoprenoid pathway produces both IPP and DMAPP after a
branching point. In contrast to E. coli, analysis of the fate of
the atoms of labeled DX5P in the bacterium Zymomonas mo-
bilis [31] and plant cells [32] are consistent with the presence
either of a single route or, in the case of a putative branching
leading separately to IPP and DMAPP, of a largely predom-
inant route for IPP synthesis. In the latter case, the presence
of functional IPP isomerase would be essential. Therefore, it is
likely that branching of the MVA-independent isoprenoid
pathway might depend on the organism. In the case of
E. coli, the existence of two separate routes for the production
of IPP and DMAPP together with an IPP isomerase encoded
by the idi gene might optimize utilization of the two central
intermediates for isoprenoid synthesis.
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